These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 6953525)

  • 1. [Effect of pharmacologically active agents on the transformation of cystamine in mouse tissues].
    Tarnopol'skaia LG
    Radiobiologiia; 1982; 22(2):246-50. PubMed ID: 6953525
    [No Abstract]   [Full Text] [Related]  

  • 2. [Chemical transformations of cystamine in mouse tissues].
    Golubentsev DA; Titov AV
    Vopr Med Khim; 1973; 19(2):177-81. PubMed ID: 4707508
    [No Abstract]   [Full Text] [Related]  

  • 3. [Mechanisms of potentiating and prolonging the radioprotective effect of multicomponent compounds].
    Vladimirov VG; Smirnova SM; Tarnopol'skaia LG
    Radiobiologiia; 1983; 23(3):389-92. PubMed ID: 6575404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Intracellular distribution of S35 in the liver and spleen in white mice after administration of S-labelled para-aminoethylisothyuronium, cystamine and 5-mercaptopentylamine disulfide].
    Vladimirov VG
    Radiobiologiia; 1967; 7(1):71-5. PubMed ID: 5608541
    [No Abstract]   [Full Text] [Related]  

  • 5. [Comparative study of cystamine conversion in the tissues of white mice and rats].
    Tarnopol'skaia LG
    Farmakol Toksikol; 1978; 41(1):93-7. PubMed ID: 624396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Chemical state and content of radioprotector in some rat tissues at early time-intervals after cystamine administration].
    Koshcheenko NN; Filippovich IV; Romantsev EF
    Vopr Med Khim; 1970; 16(1):69-72. PubMed ID: 5435390
    [No Abstract]   [Full Text] [Related]  

  • 7. [Beta-mercaptoethylamine content of mouse tissues after combined administration of cystamine and 5-methoxytryptamine].
    Mordukhovich VV
    Radiobiologiia; 1975; 15(1):132-6. PubMed ID: 1056603
    [No Abstract]   [Full Text] [Related]  

  • 8. [Species characteristics of cystamine metabolism in mice and rats].
    Titov AV; Golubentsev DA; Mikhaĭlova EG
    Radiobiologiia; 1974; 14(6):907-9. PubMed ID: 4450001
    [No Abstract]   [Full Text] [Related]  

  • 9. The toxic and protective effects of 5-methoxytryptamine and cystamine in mice in the state of hyperthyroidism and its recovery.
    Hosek B; Misustová J; Pospísil M
    Strahlentherapie; 1979 Feb; 155(2):131-6. PubMed ID: 284642
    [No Abstract]   [Full Text] [Related]  

  • 10. [Influence of 5-methoxytryptamine, cystamine, and aminopropyl-aminoethylthiophosphate on the radiosensitivity of hematopoietic stem cells].
    Abdul' IuA; Butomo NV
    Radiobiologiia; 1975; 15(5):766-8. PubMed ID: 1061207
    [No Abstract]   [Full Text] [Related]  

  • 11. [Determination of H3-mexamine in the mouse body and liver cells].
    Pavlova LM; Sverdlov AG; Grachev SA; Bagiian GA
    Radiobiologiia; 1975 MAR-APR; 15(2):306-8. PubMed ID: 1057217
    [No Abstract]   [Full Text] [Related]  

  • 12. [Radioprotective properties of some phosphorus-containing derivatives of isothiuronium].
    Il'iuchenok TIu; Frigidova LM; Zav'ialov IuV; Verkhovskiĭ IuG; Zherbin EA
    Farmakol Toksikol; 1976; 39(2):191-8. PubMed ID: 1278352
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of cystamine and 5-methoxytryptamine on the course of experimental bacteriemia in irradiated mice.
    Vejbora O; Hanovcová I; Volenec K; Dostál M
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1986; 29(4-5):493-501. PubMed ID: 2964718
    [No Abstract]   [Full Text] [Related]  

  • 14. [Nonprotein thiol concentration in different rat tissues following administration of cystamine and mexamine].
    Stoklasova A; Krzhizhala I; Ledvina M
    Radiobiologiia; 1980; 20(2):263-5. PubMed ID: 6931370
    [No Abstract]   [Full Text] [Related]  

  • 15. [Application of the methods of the mathematical theory of experiments to the development of multicomponent radioprotective preparations].
    Vladimirov VG; Zaĭtseva TG; Kamenko IP; Poddubskiĭ GA; Razorenov GI
    Radiobiologiia; 1983; 23(4):444-8. PubMed ID: 6310676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Distribution in mouse liver and spleen cell organoids of cystamine-S35 and its metabolic products].
    Pavlova LM; Bondarev GN; Sverdlov AG; Grachev SA; Leonova EV
    Radiobiologiia; 1972; 12(5):671-5. PubMed ID: 4660679
    [No Abstract]   [Full Text] [Related]  

  • 17. [Concentration of reduced glutathione and glutathione reductase activity in various rat tissues following the administration of radioprotective substances].
    Půlpánová J; Kovárová H; Ledvina M
    Radiobiol Radiother (Berl); 1982 Jan; 23(1):42-9. PubMed ID: 6953526
    [No Abstract]   [Full Text] [Related]  

  • 18. [Differences in the accumulation of cystamine in bone marrow cells determined by the nature of the salt-forming anions].
    Krasil'nikov II; Levachevskaia EI; Slavachevskaia NM; Tarnopol'skaia LG
    Radiobiologiia; 1975; 15(6):902-5. PubMed ID: 176682
    [No Abstract]   [Full Text] [Related]  

  • 19. [Radiation protection of mice with hypoxic gas mixtures after administration of anti-hypoxic agents].
    Waĭnson AA; Uriupov OIu
    Radiobiologiia; 1986; 26(3):329-33. PubMed ID: 3461496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A comparative study of the intracellular distribution of S35-cystamine in the liver and spleen of white mice and rats].
    Vladimirov VG
    Radiobiologiia; 1968; 8(2):258-61. PubMed ID: 5676554
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.